Cargando…

A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics

The vascular endothelial growth factor (VEGF) family of cytokines plays a key role in vasculogenesis, angiogenesis, and lymphangiogenesis. VEGF-A is the main member of this family, alongside placental growth factor (PlGF), VEGF-B/C/D in mammals, and VEGF-E/F in other organisms. To study the activiti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Xiaoqing, Gaucher, Jean-François, Vidal, Michel, Broussy, Sylvain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625919/ https://www.ncbi.nlm.nih.gov/pubmed/34833851 http://dx.doi.org/10.3390/molecules26226759

Ejemplares similares

Structural and ITC Characterization of Peptide‐Protein Binding: Thermodynamic Consequences of Cyclization Constraints, a Case Study on Vascular Endothelial Growth Factor Ligands
por: Gaucher, Jean‐François, et al.
Publicado: (2022)

An Overview of Biological Macromolecule Crystallization
por: Krauss, Irene Russo, et al.
Publicado: (2013)

Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat)
por: Broussy, Sylvain, et al.
Publicado: (2020)

Heterocycles in Peptidomimetics and Pseudopeptides: Design and Synthesis (†)
por: Cerminara, Iole, et al.
Publicado: (2012)

Peptides and Peptidomimetics for Antimicrobial Drug Design
por: Mojsoska, Biljana, et al.
Publicado: (2015)

Peptides and Peptidomimetics as Potential Antiobesity Agents: Overview of Current Status
por: Kumar, Maushmi S.
Publicado: (2019)

Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application
por: Sadremomtaz, Afsaneh, et al.
Publicado: (2020)

Macromolecules as targeted drugs delivery vehicles: an overview
por: Ali, Yousaf, et al.
Publicado: (2019)

Ligand effects on phase separation of multivalent macromolecules
por: Ruff, Kiersten M., et al.
Publicado: (2021)

Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of α(4)β(1) Integrin
por: Baiula, Monica, et al.
Publicado: (2023)

In Silico Design of a Peptidomimetic Carrier for Levodopa
por: Banerjee, A., et al.
Publicado: (2011)

A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities
por: Namjoo, Mohadeseh, et al.
Publicado: (2023)

Editorial: Computer-aided drug design: Drug discovery, computational modelling, and artificial intelligence
por: Ye, Fei, et al.
Publicado: (2022)

Peptidomimetics II
por: Lubell, William D
Publicado: (2016)

Isothermal Titration Calorimetry for Measuring Macromolecule-Ligand Affinity
por: Duff,, Michael R., et al.
Publicado: (2011)

Design and Synthesis of C-Terminal Modified Cyclic Peptides as VEGFR1 Antagonists
por: Wang, Lei, et al.
Publicado: (2014)

Binding Modes of Peptidomimetics Designed to Inhibit STAT3
por: Dhanik, Ankur, et al.
Publicado: (2012)

Recent Advances in Miscanthus Macromolecule Conversion: A Brief Overview
por: Mironova, Galina F., et al.
Publicado: (2023)

Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy
por: Naik, Himgauri, et al.
Publicado: (2021)

Keep it together: restraints in crystallographic refinement of macromolecule–ligand complexes
por: Steiner, Roberto A., et al.
Publicado: (2017)

Peptidomimetics in cancer targeting
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2022)

Adding Diverse Noncanonical Backbones to Rosetta: Enabling Peptidomimetic Design
por: Drew, Kevin, et al.
Publicado: (2013)

Bioinformatics and Biosimulations as Toolbox for Peptides and Peptidomimetics Design: Where Are We?
por: D’Annessa, Ilda, et al.
Publicado: (2020)

Combating amyloid-induced cellular toxicity and stiffness by designer peptidomimetics
por: Konar, Mouli, et al.
Publicado: (2021)

Rational Design of a Peptidomimetic Inhibitor of Gelsolin Amyloid Aggregation
por: Bollati, Michela, et al.
Publicado: (2022)

Probing the Nanoscopic Thermodynamic Fingerprint of Paramagnetic Ligands Interacting with Amphiphilic Macromolecules
por: Reichenwallner, Jörg, et al.
Publicado: (2017)

Vascular Endothelial Growth Factor Ligands and Receptors in Breast Cancer
por: Brogowska, Klaudia Katarzyna, et al.
Publicado: (2023)

Synthesis, Pharmacological Evaluation, and Computational Studies of Cyclic Opioid Peptidomimetics Containing β(3)-Lysine
por: Wtorek, Karol, et al.
Publicado: (2021)

Conformationally Constrained Histidines in the Design of Peptidomimetics: Strategies for the χ-Space Control
por: Stefanucci, Azzurra, et al.
Publicado: (2011)

Rationally Designed Peptidomimetic Modulators of Aβ Toxicity in Alzheimer's Disease
por: Rajasekhar, K., et al.
Publicado: (2015)

Design of Anti-Angiogenic Peptidomimetics and Evaluation their Biological Activity by In Vitro Assays
por: Ghadam, Mona, et al.
Publicado: (2020)

Exploiting Knowledge on Structure–Activity Relationships for Designing Peptidomimetics of Endogenous Peptides
por: Perez, Juan J.
Publicado: (2021)

Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm
por: Kuppusamy, Rajesh, et al.
Publicado: (2023)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

Using the ribosome to synthesize peptidomimetics
por: Freidinger, Roger M
Publicado: (2009)

Short Cationic Peptidomimetic Antimicrobials
por: Kuppusamy, Rajesh, et al.
Publicado: (2019)

Promising Antibiofilm Activity of Peptidomimetics
por: Gomes Von Borowski, Rafael, et al.
Publicado: (2018)

Peptidomimetics Therapeutics for Retinal Disease
por: Parsons, Dylan E., et al.
Publicado: (2021)

Cell-free Biosynthesis of Peptidomimetics
por: Lee, Kanghun, et al.
Publicado: (2023)

Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A
por: Gaucher, Jean-François, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o7rs5buhsdpl7g8kebfgcoqhsn